Boston Research & Management Inc / MRK
Boston Research & Management Inc’s Merck & Co Inc Position
Does Boston Research & Management Inc own Merck & Co Inc (MRK)? Yes — 66.6K shares worth $8M (+1.90% of its 13F portfolio) as of Q1 2026, up from 66.0K shares the prior filed quarter.
Position Value
$8M
Q1 2026
Shares
66.6K
% of Portfolio
+1.90%
Quarters Held
29
currently held
Position History MRK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 66.6K | $8M | +1.90% |
| Q4 2025 | 66.0K | $7M | +1.60% |
| Q3 2025 | 67.6K | $6M | +1.25% |
| Q2 2025 | 67.4K | $5M | +1.27% |
| Q1 2025 | 62.9K | $6M | +1.40% |
| Q4 2024 | 64.1K | $6M | +1.56% |
| Q3 2024 | 62.3K | $7M | +1.66% |
| Q2 2024 | 60.8K | $8M | +1.90% |
| Q1 2024 | 61.5K | $8M | +2.01% |
| Q4 2023 | 61.5K | $7M | +1.78% |
| Q3 2023 | 60.1K | $6M | +1.83% |
| Q2 2023 | 60.4K | $7M | +1.97% |
| Q1 2023 | 60.4K | $6M | +1.92% |
| Q4 2022 | 61.3K | $7M | +2.10% |
| Q3 2022 | 62.5K | $5M | +1.83% |
| Q2 2022 | 62.4K | $6M | +1.84% |
| Q1 2022 | 62.6K | $5M | +1.49% |
| Q4 2021 | 63.1K | $5M | +1.32% |
| Q3 2021 | 63.0K | $5M | +1.41% |
| Q2 2021 | 60.0K | $5M | +1.41% |
| Q1 2021 | 56.6K | $4M | +1.40% |
| Q4 2020 | 51.4K | $4M | +1.46% |
| Q3 2020 | 48.7K | $4M | +1.58% |
| Q2 2020 | 49.8K | $4M | +1.60% |
| Q1 2020 | 48.5K | $4M | +1.87% |
| Q4 2019 | 48.3K | $4M | +1.65% |
| Q3 2019 | 48.3K | $4M | +1.61% |
| Q2 2019 | 47.5K | $4M | +1.61% |
| Q1 2019 | 46.6K | $4M | +1.62% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Research & Management Inc’s full portfolio or all institutional holders of MRK.